Login / Signup

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.

Michael D KinnamanSimone ZaccariaAlvin P Makohon-MooreBrian J ArnoldMax Fine LevineGunes GundemJuan Esteban Arango OssaDominik GłodzikM Irene Rodríguez-SánchezNancy BouvierShanita LiEmily StockfischMarisa DuniganCassidy CobbsUmeshkumar K BhanotDaoqi YouKatelyn MullenJerry P MelchorMichael V OrtizTara J O'DonohueEmily K SlotkinLeonard H WexlerFilemon Dela CruzMeera R HameedJulia L Glade BenderWilliam D TapPaul A MeyersElli PapaemmanuilAndrew L KungChristine A Iacobuzio-Donahue
Published in: Cancer research (2023)
The chemoresistant population in recurrent osteosarcoma is subclonal at diagnosis, emerges at the time of primary resection due to selective pressure from neoadjuvant chemotherapy, and is characterized by unique oncogenic amplifications.
Keyphrases
  • copy number
  • neoadjuvant chemotherapy
  • mitochondrial dna
  • locally advanced
  • genome wide
  • lymph node
  • sentinel lymph node
  • dna methylation
  • rectal cancer
  • squamous cell carcinoma
  • gene expression
  • radiation therapy